The lncRNA ZNF667-AS1 Inhibits Propagation, Invasion, and Angiogenesis of Gastric Cancer by Silencing the Expression of N-Cadherin and VEGFA

Table 1

Correlation analysis of lncRNA ZNF667-AS1 levels and clinical features of patients with gastric cancer.

Clinical characteristics	n	lncRNA ZNF667-AS1 expression	t/F
Gender
Male	12	1.83 ± 0.94	0.4078	0.6883
Female	8	1.66 ± 0.87
Age
>60	15	1.72 ± 1.05	0.7054	0.4896
≤60	5	2.11 ± 1.14
BMI
>24 kg/m^2	9	1.56 ± 0.76	0.8827	0.3891
≤24 kg/m^2	11	1.92 ± 1.01
TNM stage
IIb	10	2.21 ± 0.89	3.878	0.0410
III	5	1.46 ± 0.83
IV	5	0.98 ± 0.69
Lymph node metastasis
Yes	13	1.29 ± 0.61	2.235	0.0383
No	7	2.15 ± 1.13